Stocks and Investing
by (remove) : Silvan Tuerkcan
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Silvan Tuerkcan
RSSJSONXMLCSV
Mon, September 30, 2024
Mon, September 16, 2024
Tue, September 10, 2024
Fri, September 6, 2024
Tue, September 3, 2024
Thu, June 20, 2024
Mon, May 13, 2024
Tue, April 30, 2024
Thu, April 25, 2024
Mon, April 22, 2024
Mon, April 1, 2024
Fri, March 22, 2024
Wed, March 20, 2024
Mon, March 18, 2024
Fri, March 1, 2024
Thu, February 15, 2024
Wed, January 24, 2024
Tue, December 5, 2023
Tue, September 26, 2023
Tue, August 15, 2023
Mon, August 14, 2023
Wed, July 26, 2023
Fri, June 30, 2023
Mon, June 26, 2023
Thu, May 18, 2023
Tue, May 16, 2023
Thu, March 30, 2023
Wed, March 29, 2023
Fri, March 24, 2023
Tue, February 14, 2023

Silvan Tuerkcan Reiterated (BNTC) at Buy and Held Target at $16 on, Sep 30th, 2024


Published on 2024-10-28 14:31:00 - WOPRAI, Silvan Tuerkcan
  Print publication without navigation


Silvan Tuerkcan of JMP Securities, Reiterated "Benitec Biopharma Inc." (BNTC) at Buy and Held Target at $16 on, Sep 30th, 2024.

Silvan has made no other calls on BNTC in the last 4 months.



There are 3 other peers that have a rating on BNTC. Out of the 3 peers that are also analyzing BNTC, 0 agree with Silvan's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Silvan


  • Debjit Chattopadhyay of "Guggenheim" Initiated at Strong Buy and Held Target at $17 on, Thursday, September 12th, 2024
  • Mani Foroohar of "Leerink Partners" Initiated at Buy and Held Target at $13 on, Monday, July 22nd, 2024
  • Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $30 on, Thursday, June 13th, 2024
Contributing Sources